Several studies have since illustrated the widespread impact of NLRP3 inflammasome activation in diabetic nephropathy through its role in glomerular injury (Xu et al., 2021; Zhan et al., 2020; Shen et al.,2022; Feng et al., 2021). This evidence concerns the gene NLRP3 and diabetic kidney disease.